Danaher to Acquire Abcam

WASHINGTON, Aug. 28, 2023 /PRNewswire/ — Danaher Corporation (NYSE: DHR) (“Danaher” or the “Company”), a global science and technology innovator, announced today that it has entered into a definitive agreement to acquire Abcam plc (NASDAQ: ABCM), a leading global supplier of protein consumables, pursuant to which Danaher will acquire all of the outstanding shares of... Read more

Danaher Declares pro Rata Dividend of Veralto Common Stock and Announces Expected “When-issued” Trading of Veralto Common Stock

Danaher Declares pro Rata Dividend of Veralto Common Stock and Announces Expected “When-issued” Trading of Veralto Common Stock WASHINGTON, Aug. 25, 2023 /PRNewswire/ — Danaher Corporation (NYSE: DHR) today announced that it expects to complete the previously announced separation of Veralto Corporation on September 30, 2023, the first day of Danaher’s fiscal fourth quarter. The... Read more

Danaher Releases 2023 Sustainability Report

WASHINGTON, Aug. 16, 2023 /PRNewswire/ — Danaher Corporation (NYSE: DHR) (“Danaher” or the “Company”), the global science and technology innovator, today published its 2023 Sustainability Report which conveys the depth and scope of Danaher’s sustainability program and highlights important milestones the Company achieved during the past year. “We are proud of the progress we are... Read more

Danaher Reports Second Quarter 2023 Results

WASHINGTON, July 25, 2023 /PRNewswire/ — Danaher Corporation (NYSE: DHR) (the “Company”) today announced results for the second quarter 2023.  Net earnings refer to net earnings attributable to common shareholders. For the quarter ended June 30, 2023 net earnings were $1.1 billion, or $1.49 per diluted common share and non-GAAP adjusted diluted net earnings per common... Read more

Danaher Schedules Second Quarter 2023 Earnings Conference Call

WASHINGTON, June 20, 2023 /PRNewswire/ — Danaher Corporation (NYSE: DHR) announced that it will webcast its quarterly earnings conference call for the second quarter 2023 on Tuesday, July 25, 2023 beginning at 8:00 a.m. ET and lasting approximately 1 hour. During the call, the company will discuss its financial performance, as well as future expectations. The... Read more

Danaher Reports First Quarter 2023 Results

WASHINGTON, April 25, 2023 /PRNewswire/ — Danaher Corporation (NYSE: DHR) (the “Company”) today announced results for the first quarter 2023.  Net earnings refer to net earnings attributable to common shareholders. For the quarter ended March 31, 2023 net earnings were $1.4 billion, or $1.94 per diluted common share and non-GAAP adjusted diluted net earnings per... Read more

Danaher Announces Conversion Date for Series B Mandatory Convertible Preferred Stock

Danaher Announces Conversion Date for Series B Mandatory Convertible Preferred Stock WASHINGTON, April 10, 2023 /PRNewswire/ — Danaher Corporation (NYSE: DHR) announced today that its 5.00% Series B Mandatory Convertible Preferred Stock (the “Preferred Stock”), will automatically convert into shares of the Company’s common stock on April 17, 2023 (the “Conversion Date”). The conversion rate... Read more

Danaher Schedules First Quarter 2023 Earnings Conference Call

WASHINGTON, March 27, 2023 /PRNewswire/ — Danaher Corporation (NYSE: DHR) announced that it will webcast its quarterly earnings conference call for the first quarter 2023 on Tuesday, April 25, 2023 beginning at 8:00 a.m. ET and lasting approximately 1 hour. During the call, the company will discuss its financial performance, as well as future expectations.... Read more

Danaher Partners with the University of Pennsylvania's Center for Cellular Immunotherapies to Address Manufacturing Challenges Impacting the Uptake of Cell Therapies

Danaher Partners with the University of Pennsylvania’s Center for Cellular Immunotherapies to Address Manufacturing Challenges Impacting the Uptake of Cell Therapies WASHINGTON, March 7, 2023 /PRNewswire/ — Danaher Corporation (NYSE: DHR), a global science and technology innovator, today announced a strategic partnership with the University of Pennsylvania (Penn) focusing on cell therapy innovation. The multi-year... Read more

Danaher Announces New Environmental and Applied Solutions Company to Be Named Veralto

Danaher Announces New Environmental and Applied Solutions Company to Be Named Veralto WASHINGTON, Feb. 8, 2023 /PRNewswire/ — Danaher Corporation (NYSE: DHR) (“Danaher”) today announced that Veralto Corporation (“Veralto” or the “Company”) will be the name of the separate public company Danaher intends to create in the fourth quarter of 2023.  Veralto will be comprised... Read more